Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter]

Drug Des Devel Ther. 2019 May 14:13:1687-1688. doi: 10.2147/DDDT.S207537. eCollection 2019.

Authors

Mitsuhiro Abe¹, Kenji Tsushima^{1

2}, Koichiro Tatsumi¹

Affiliations

¹ Department of Respirology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba city, Chiba 260-8670, Japan.
² Department of Pulmonary Medicine, International University of Health and Welfare, School of Medicine, Narita city, Chiba 286-8686, Japan.

No abstract available

Publication types

Comment

MeSH terms

Humans
Idiopathic Pulmonary Fibrosis*
Indoles
Protein Kinase Inhibitors
Retrospective Studies

Substances

Indoles
Protein Kinase Inhibitors
nintedanib